Debiopharm Innovation Fund Investors
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Invests into
Founded Date:
2012-01-01
Investor Type:
Venture Capital
Employee Number:
1-10
Investment Stage:
Late Stage Venture, Venture
Funding Status:
N/A
Number Of Exists:
6
Acquisitions Number:
NA
Investors Number:
24
Zip:
NA
Industry:
Imaging
Headquarters:
Lausanne, Vaud, Switzerland
Estimated Revenue:
$4.7M.